Also trades as: AQS.V (TSXV) · $vol 0M
AQSZF OTC
Aequus Pharmaceuticals Inc.
1W: +0.0%
1M: +0.0%
3M: -73.1%
YTD: -41.7%
1Y: -66.7%
3Y: -96.5%
5Y: -99.4%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$2M
+27.8% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$2M
+27.8% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$120K
-50.7% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1M | -$2M | -$3M | -$3M | -$2M |
| Depreciation & Amort. | $211K | $128K | $130K | $138K | $132K |
| Stock-Based Comp. | $298K | $216K | $41K | $51K | $17K |
| Change in Working Capital | -$522K | $29K | $446K | $387K | $315K |
| Other Non-Cash Items | $254K | $268K | $368K | $94K | $58K |
| Operating Cash Flow | -$805K | -$1M | -$2M | -$2M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | -$12K | -$4K | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | -$504K | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $45K |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$12K | -$508K | $0 | $0 | $45K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$104K | -$148K | -$189K | -$156K | $1M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $2M | $0 |
| Financing Cash Flow | $2M | $2M | -$189K | $2M | $1M |
| Net Change in Cash | $1M | $718K | -$2M | -$80K | -$120K |
| Cash End of Period | $2M | $2M | $250K | $170K | $50K |
| Free Cash Flow | -$817K | -$1M | -$2M | -$2M | -$2M |